Skip to main content
. 2022 Oct 7;13:998140. doi: 10.3389/fimmu.2022.998140

Figure 4.

Figure 4

Kaplan–Meier survival analysis between the two risk groups in subgroups stratified by clinical characteristics: including age [>60 years vs. ≤60 years] (A, B), ER stage [negative vs. positive] (C, D), HER2 stage [negative vs. positive] (E, F), PR stage [negative vs. positive] (G, H), stages [stage1-2 vs. stage3-4] (I, J), AJCC T stage [T1-2 vs. T3-4] (K, L), AJCC N stage [N0-1 vs. T2-3] (M, N), and AJCC M stage [M0 vs. M1] (O, P), respectively.